Beltran Pedro bought BBOT

May 10, 2026 · Form 4 insider transaction

Beltran Pedro bought 1,103,837 shares of BridgeBio Oncology Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,103,837
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 10, 2026
Filing dateMay 12, 2026
Shares owned after1,103,837
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of April 20, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.

View the original Form 4 on SEC EDGAR